Markets:

Overview

News

Currencies

International

Treasuries

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

76.50 +21.72 (+39.65%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Forte Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

72 Biggest Movers From Yesterday ↗

September 08, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 07, 2021

Gainers Surrozen (NASDAQ:SRZN) stock rose 33.14% to $9.64 during Tuesday's regular session. The company's market cap stands at $351.2 million. ZIOPHARM Oncology (...

Via Benzinga

Unusual Options Activity Insight: Forte Biosciences ↗

August 06, 2021

On Friday, shares of Forte Biosciences (NASDAQ:FBRX) saw u...

Via Benzinga

53 Biggest Movers From Friday ↗

September 07, 2021

Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera...

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

September 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

5 Value Stocks In The Healthcare Sector ↗

September 06, 2021

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week ↗

September 05, 2021

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm

September 03, 2021

From The Schall Law Firm

Via Business Wire

Mid-Afternoon Market Update: Crude Oil Down 1%; MongoDB Shares Jump After Q2 Results ↗

September 03, 2021

Toward the end of trading Friday, the Dow traded down 0.11% to 35,403.67 while the NASDAQ rose 0.23% to 15,366.71. The S&P also rose, gaining 0.04% to 4,538.92. The U.S. has...

Via Benzinga

Topics Stocks

Why Forte Biosciences Stock Is Down Over 80% Today ↗

September 03, 2021

Forte Biosciences (NASDAQ: FBRX) is tanking today after the company announced the clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 03, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Dow Steps Back, Nasdaq Reaches For More Records ↗

September 03, 2021

The Dow Jones Industrial Index is taking a breather today, last seen down 56 points, after August's jobs report came in much lower than expected.

Via Talk Markets

Topics Stocks

Mid-Day Market Update: Gold Rises 1%; Forte Biosciences Shares Plunge ↗

September 03, 2021

Midway through trading Friday, the Dow traded down 0.23% to 35,361.40 while the NASDAQ rose 0.02% to 15,333.95. The S&P also fell, dropping 0.22% to 4,527.17. The U.S. has the...

Via Benzinga

Topics Stocks

35 Stocks Moving In Friday's Mid-Day Session ↗

September 03, 2021

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 35% to $7.43. Cellect Biotechnology announced the first ApoGraft transplantation in a Leukemia patient in a...

Via Benzinga

Why Forte Biosciences Stock Is Imploding Today ↗

September 03, 2021

The company announced dismal results from a phase 2 study of its only pipeline candidate.

Via The Motley Fool

Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August ↗

September 03, 2021

Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66. The U.S....

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 03, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million....

Via Benzinga

20 Stocks Moving in Friday's Pre-Market Session ↗

September 03, 2021

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first...

Via Benzinga

A Peek Into The Markets: US Stock Futures Rise; All Eyes On Jobs Report ↗

September 03, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the release of jobs report for August. Analysts expect nonfarm payrolls rising 740,000 for...

Via Benzinga

Forte Biosciences Just Plummeted 80%: Here's Why ↗

September 02, 2021

A biopharmaceutical company focused on the development of dermatology treatments saw a sharp drop after hours Thursday. What Happened: The clinical trial of Forte Biosciences (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 02, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance

September 02, 2021

From Forte Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 18, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX...

Via Benzinga

48 Stocks Moving In Tuesday's Mid-Day Session ↗

August 17, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA...

Via Benzinga

66 Biggest Movers From Yesterday ↗

August 18, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 17, 2021

Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374...

Via Benzinga

25 Stocks Moving in Tuesday's Pre-Market Session ↗

August 17, 2021

Gainers Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday. LM Funding America, Inc. (NASDAQ: LMFA) rose...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 16, 2021

Gainers Strata Skin Sciences (NASDAQ:SSKN

Via Benzinga

Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7

August 16, 2021

From Forte Biosciences, Inc.

Via Business Wire

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

August 02, 2021

From Forte Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.